These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20501890)

  • 1. Maintenance of risk factor control in diabetic patients with and without mental health conditions after discharge from a cardiovascular risk reduction clinic.
    Cohen LB; Taveira TH; Wu WC; Pirraglia PA
    Ann Pharmacother; 2010; 44(7-8):1164-70. PubMed ID: 20501890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: a randomized controlled trial.
    Taveira TH; Wu WC
    Diabetes Res Clin Pract; 2014 Sep; 105(3):327-35. PubMed ID: 24969964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience.
    Pearson GJ; Olson KL; Panich NE; Majumdar SR; Tsuyuki RT; Gilchrist DM; Damani A; Francis GA
    Vasc Health Risk Manag; 2008; 4(5):1127-35. PubMed ID: 19183763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions.
    Taveira TH; Pirraglia PA; Cohen LB; Wu WC
    Prev Cardiol; 2008; 11(4):195-200. PubMed ID: 19476571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of cardiovascular risk goals in veterans with diabetes after discharge from a cardiovascular risk reduction clinic.
    Pirraglia PA; Taveira TH; Cohen LB; Dooley A; Wu WC
    Prev Cardiol; 2009; 12(1):3-8. PubMed ID: 19301685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist-led cardiac risk reduction model.
    Taveira TH; Wu WC; Martin OJ; Schleinitz MD; Friedmann P; Sharma SC
    Prev Cardiol; 2006; 9(4):202-8. PubMed ID: 17085982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study.
    Wan EYF; Yu EYT; Chin WY; Fung CSC; Fong DYT; Choi EPH; Chan AKC; Lam CLK
    Diabetes Care; 2018 Jun; 41(6):1134-1141. PubMed ID: 29592967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk.
    Kirsh S; Watts S; Pascuzzi K; O'Day ME; Davidson D; Strauss G; Kern EO; Aron DC
    Qual Saf Health Care; 2007 Oct; 16(5):349-53. PubMed ID: 17913775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of Goal Blood Pressure, Cholesterol, and A1C Levels in Veterans With Type 2 Diabetes After Discharge From a Pharmacist-Managed Ambulatory Care Clinic.
    Erwin PB; Pitlick MK; Peters GL
    Diabetes Spectr; 2015 Nov; 28(4):237-44. PubMed ID: 26600724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 13. Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
    Hypertension; 2017 Dec; 70(6):1273-1282. PubMed ID: 29038204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cholesterol, Hypertension, And Glucose Education (CHANGE) study: results from a randomized controlled trial in African Americans with diabetes.
    Crowley MJ; Powers BJ; Olsen MK; Grubber JM; Koropchak C; Rose CM; Gentry P; Bowlby L; Trujillo G; Maciejewski ML; Bosworth HB
    Am Heart J; 2013 Jul; 166(1):179-86. PubMed ID: 23816038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
    Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
    J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus.
    Göbl CS; Brannath W; Bozkurt L; Handisurya A; Anderwald C; Luger A; Krebs M; Kautzky-Willer A; Bischof MG
    Gend Med; 2010 Dec; 7(6):593-9. PubMed ID: 21195359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacist-managed cardiovascular risk-reduction clinic for individuals experiencing serious mental illness.
    Gonzalvo JD; Hamm JA; Shan M
    J Am Pharm Assoc (2003); 2019; 59(5):698-703. PubMed ID: 31324536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus.
    Yamamoto M; Fujihara K; Ishizawa M; Osawa T; Kaneko M; Ishiguro H; Matsubayashi Y; Seida H; Yamanaka N; Tanaka S; Kodama S; Hasebe H; Sone H
    J Am Heart Assoc; 2019 Apr; 8(8):e010627. PubMed ID: 30971163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variability in response to renin angiotensin aldosterone system inhibition predicts cardiovascular outcome in patients with type 2 diabetes: A primary care cohort study.
    Apperloo EM; Pena MJ; de Zeeuw D; Denig P; Heerspink HJL
    Diabetes Obes Metab; 2018 Jun; 20(6):1377-1383. PubMed ID: 29345404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.